Funding for this research was provided by:
Vital Pharmaceuticals Inc. (160292)
Text and Data Mining valid from 2019-11-19
Received: 23 May 2019
Accepted: 9 September 2019
First Online: 19 November 2019
Ethics approval and consent to participate
: All procedures of the study were approved by the University of South Alabama Institutional Review Board (Protocol # 966357). All experimental procedures involved in the study conformed to the ethical considerations outlined by the Declaration of Helsinki.
: Not applicable.
: Vital Pharmaceuticals Inc. (VPX Inc.) provided funding to perform the study and for publication. The authors declare no competing interests, financial or otherwise, in the outcome of the study. NAS has received funding from VPX Inc. to present at a scientific conference.